Hopefully it won't be a party like the type of party hollywood director Brian Singer throws. That is not the coming out party we want. There are still a lot of missing pieces to the puzzle. Like financing etc. Clinical trials aren't cheap no matter how small they are. And since we don't know squat as our illustrious CEO has kept us in the dark, we still wait to find out. But all of this is moot if the FDA doesn't approve HemaX for P1 trials. Go BMSN Bluecheese Muffins Smell Nasty